Deel vs Remote for Biotech Consultants: A Worked Example

With a compressed timeline, a contractor agreement is often the fastest path to having someone actually drafting sections of the submission, whether you set it up through Deel or another platform; confirm classification rules for the worker's country first. Contractor onboarding through a platform like Deel can often move faster than setting up an employment entity, which matters when a sponsor's regulatory deadline isn't moving to accommodate your hiring process, though timing still depends on the country and your paperwork.

The tradeoff shows up if this writer becomes a recurring resource across multiple sponsor engagements rather than a single retainer. A contractor relationship that's renewed project after project, exclusively for your firm, starts to look like ongoing employment regardless of how each engagement was scoped, which is the same pattern that shows up across every industry using this staffing model.

A data scientist building analysis pipelines or statistical models that become part of your consultancy's proprietary methodology is a different risk profile than a writer working from a sponsor's own data and templates. If that person's work becomes something your firm reuses across multiple clients, effectively part of your intellectual property rather than a one-off deliverable, Remote's owned-entity structure gives you a cleaner invention-assignment position than a contractor agreement would.

Choose Remote for the data scientists and senior technical staff whose work builds your firm's own methodology. Choose Deel for the wider bench of writers and coordinators supporting individual sponsor engagements.

Regulatory writing in life sciences tends to carry documentation and version-control expectations closer to a formally regulated environment than most consulting work, even when the writer isn't personally operating inside a GxP-certified facility. Neither Deel nor Remote manages document version control, audit trails, or the review chain your firm's quality process requires. Build those expectations into onboarding regardless of contract type, since a sponsor auditing your consultancy's process won't distinguish between a contractor's documentation habits and an employee's.

Payroll is typically a meaningful share of revenue for a technical consultancy built on specialized staff hours¹, and that fully loaded cost, once statutory benefits in the writer's country are added, needs to fit inside what the sponsor retainer actually supports. Get that number from Deel or Remote before you commit the hire's cost against the engagement's budget.

Time to fill a specialized regulatory or data science role tends to run longer than filling a generalist hire², since the combination of scientific background and regulatory writing experience is narrow in most countries. Start recruiting as soon as a sponsor engagement is likely, rather than after the contract is signed.

Deel and Remote both handle employment paperwork, payroll, and statutory compliance. Neither one will tell you whether a regulatory writer's draft actually meets a specific agency's submission conventions, or whether your quality-control process catches an error before it reaches the sponsor. Those are technical and process questions that sit with your consultancy's scientific leadership, separate from the employment structure underneath the hire.

Beyond writers and data scientists, many biotech consultancies also staff study coordinators supporting clinical or preclinical work, roles that often involve direct contact with study sites, vendor coordination, and sometimes access to subject-level data governed by its own confidentiality and privacy expectations. This role tends to sit closer to the writer pattern than the data-scientist pattern: staffed per study, with a natural end point when the study wraps, making a contractor agreement through Deel a reasonable starting point.

The exception is a coordinator your firm keeps engaging across consecutive studies for the same or different sponsors. At that point, treat the relationship the same way you would a recurring writer: as a candidate for EOR employment rather than a series of renewed short-term agreements.

A sponsor's own quality assurance function may, during an audit of your consultancy, ask how contributing staff are employed and what confidentiality obligations bind them, particularly for anyone who touched study data directly. Having a clear, documented answer, especially for study coordinators and writers with direct data access, tends to go over better in that conversation than an informal explanation assembled on the spot.

Be ready to answer these questions if a sponsor audits your staffing:

• How each contributing staff member is employed, whether as a contractor or as an EOR employee.
• What confidentiality obligations bind them, particularly anyone who touched study data directly.
• How documentation and version control are handled for regulatory writing, which platforms do not manage for you.
• Who reviewed the work before it reached the sponsor, and how your quality-control process would catch an error.